BCAB logo

BCABBioAtla Inc

$3.76
$0.21
(6.11%)
Today
Closed $3.65
$0.11
(3.01%)
After Hours
Updated: 06:16 PM EDT
EarningsAug 6
Mkt Cap$5.71M
Vol38,975.00

About

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
41

Frequently Asked Questions

What is Market Cap of BioAtla Inc?
What is the 52-week high for BioAtla Inc?
What is the 52-week low for BioAtla Inc?
What is BioAtla Inc stock price today?
What was BioAtla Inc stock price yesterday?
What is the PE ratio of BioAtla Inc?
What is the Price-to-Book ratio of BioAtla Inc?
What is the 50-day moving average of BioAtla Inc?
How many employees does BioAtla Inc have?

Advertisement|Remove ads.